Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2022-08-12 Foreign Filer Report
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
ENHERTU APPROVED IN US FOR HER2-MUTANT NSCLC
Foreign Filer Report
2022-08-12 English
Enhertu approved in US for HER2-mutant NSCLC
Regulatory Filings Classification · 98% confidence The document is an official announcement released via RNS (RNS Number : 8362V) on August 12, 2022. It details the US FDA approval of the drug Enhertu for a specific type of NSCLC, citing clinical trial results (DESTINY-Lung02) and including financial milestone details. This is a specific, material corporate event announcement that is not a full annual report (10-K), an earnings release (ER), or a general proxy statement. Since it is a formal, time-sensitive regulatory announcement that doesn't fit the more specific categories like DIV, DIRS, or MANG, it falls best under the general Regulatory Filings category (RNS), which serves as a catch-all for such official disclosures.
2022-08-12 English
ACQUISITION OF TENEOTWO COMPLETED
Foreign Filer Report
2022-08-11 English
Acquisition of TeneoTwo completed
M&A Activity Classification · 99% confidence The document is identified by the 'RNS Number' header and the closing statement indicating it is provided by 'RNS, the news service of the London Stock Exchange.' The content details the completion of an acquisition (AstraZeneca acquiring TeneoTwo) and associated financial considerations. This type of announcement, which is a material corporate event disclosure distributed via the official regulatory news service (RNS), fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a director's dealing (DIRS). It is a general regulatory announcement.
2022-08-11 English
ENHERTU APPROVED IN THE US FOR HER2-LOW MBC
Foreign Filer Report
2022-08-08 English
Enhertu approved in the US for HER2-low mBC
Regulatory Filings Classification · 99% confidence The document is a press release dated August 8, 2022, originating from AstraZeneca PLC, identified by the RNS Number 2205V, which is characteristic of a Regulatory News Service announcement. The content details the US FDA approval of Enhertu for HER2-low metastatic breast cancer, citing clinical trial results (DESTINY-Breast04) and including financial considerations ($200m milestone payment). This is a specific announcement regarding a regulatory event and key business development, not a comprehensive annual report (10-K), a quarterly report (IR), or a general earnings release (ER). Since it is a formal, time-sensitive announcement disseminated via the RNS system, and it doesn't fit the specific categories like DIV, DIRS, or MANG, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that doesn't map perfectly to the other specific types, although it is highly specific content. Given the context of RNS being the fallback for miscellaneous regulatory filings, RNS is the best fit here, as it is not an announcement *about* a report (RPA), but the report/announcement itself.
2022-08-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.